It’s an interesting idea, but we think our unique advantage is being able to generate scalable,, relatable, and reliable data in-house. Clinical data are extremely challenging to work with from a statistical perspective (the number of confounders is astounding, and once you stratify you may be left with very few samples). That said, real-world evidence is certainly interesting from a clinical development perspective for understanding the patient landscape, longitudinal disease progression, and for informing patient selection strategies in clinical trials; and other population-scale datasets may be of interest for advancing our discovery and development pipelines.